| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Breast Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Breast Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Breast Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Skin Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| letrozole | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Aromatase Inhibitors | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Cancer Institute of Canada | |||||
| National Cancer Institute (NCI) | |||||
| North Central Cancer Treatment Group | |||||
| International Breast Cancer Study Group | |||||
| Eastern Cooperative Oncology Group | |||||
| Southwest Oncology Group | |||||
| Cancer and Leukemia Group B | |||||
| European Organization for Research and Treatment of Cancer | |||||
|
